Medicine and Dentistry
Mesothelioma
100%
Patient
71%
Pleura Mesothelioma
45%
Gene
43%
Odds Ratio
39%
Survival
31%
Chemotherapy
31%
Biological Marker
28%
Platinum
27%
Diagnosis
21%
Overall Survival
21%
Asbestos Exposure
20%
Neoplasm
20%
Pemetrexed
19%
Germline Mutation
18%
Marker
18%
Asbestos
17%
Cancer Susceptibility
15%
Inpatient
15%
Woman
14%
Therapeutic Procedure
13%
DNA Repair
12%
Supportive Care
11%
Next Generation Sequencing
11%
Cancer
10%
Homologous Recombination
10%
Age
10%
Effusion
8%
Tumor Suppressor Gene
8%
BRCA1
8%
Second Cancer
7%
Cancer Diagnosis
7%
Specimen
7%
Radiation Therapy
7%
Immunohistochemistry
6%
Malignant Neoplasm
6%
Prevalence
5%
Sarcomatoid
5%
Single Nucleotide Polymorphism
5%
Biopsy
5%
Loss of Function Mutation
5%
Genotype
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mesothelioma
100%
Pleura Mesothelioma
45%
Survival
31%
Biological Marker
28%
Platinum
27%
Asbestos Exposure
23%
Overall Survival
21%
Neoplasm
20%
Pemetrexed
19%
Cancer Susceptibility
15%
Effusion
8%
Malignant Neoplasm
6%
Prevalence
5%
Biochemistry, Genetics and Molecular Biology
Nested Gene
40%
BAP1
30%
Mutation
28%
Phosphorylase
19%
Germline Mutation
18%
DNA Repair
12%
Survival
11%
Germline
11%
Overall Survival
11%
Homologous Recombination
10%
Sample
8%
BRCA1
8%
Medline
7%
Electric Potential
7%
Age
7%
Prevalence
5%
Gene Mutation
5%
Tissue Section
5%
Single-Nucleotide Polymorphism
5%
Loss of Function Mutation
5%
Genotyping
5%